Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

INTRODUCTION: Estrogen deprivation using aromatase inhibitors is one of the standard treatments for postmenopausal women with estrogen receptor (ER)-positive breast cancer. However, one of the consequences of prolonged estrogen suppression is acquired drug resistance. Our group is interested in stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis-Wambi, Joan S, Kim, Helen R, Wambi, Chris, Patel, Roshani, Pyle, Jennifer R, Klein-Szanto, Andres J, Jordan, V Craig
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656901/
https://www.ncbi.nlm.nih.gov/pubmed/19061505
http://dx.doi.org/10.1186/bcr2208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656901/
https://www.ncbi.nlm.nih.gov/pubmed/19061505
http://dx.doi.org/10.1186/bcr2208

Ejemplares similares